Heparin induced thrombocytopenia. A frequently unrecognised complication after major orthopedic surgery;Die heparininduzierte thrombozytopenie. Eine oft verkannte komplikation nach größeren orthopädischen eingriffen

Orthopade

Volumn 33, Issue 11, 2004, Pages 1300-1308

  Picker, S M ^a   Gathof, B S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anticoagulation; Heparin induced thrombocytopenia; HIT; Thromboembolic complications; Vessel blockage

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ARTICLE; ENDOTHELIUM CELL; HUMAN; IMMUNITY; ORTHOPEDIC SURGERY; POSTOPERATIVE THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMPUTATION; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; ORTHOPEDICS; OSTEOARTHRITIS, HIP; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; TIME FACTORS;

EID: 11144303457     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-004-0695-3     Document Type: Article

References (42)

1. Amiral J, Marfaing-Koka A, Wolf M et al. (1994) Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88: 410-416
2. Amiral J (1997) Diagnostic tests in heparin-induced thrombocytopenia. Platelets 8: 68-72
3. Arthur CK, Grant SJB, Murray WK, Isbister JB, Stiel JN, Lauer CS (1985) Heparin-associated acute adreal insufficiency. Aust N Z J Med 15:454-455
4. Chong BH (1989) Heparin-induced thrombocytopenia. Blut 58:53-57
5. Danaparoid bei Heparin-induzierter Thrombozytopenie Typ II (1998) Arzneimitteltherapie 16/41
6. Ernest D, Fisher MM (1991) Heprain-induced thrombocytopenia complicated by bilateral adrenal hemorrhage. Int Care Med 17:238-240
7. Fitton A (2003) Heparin-induced thrombocytopenia and the role of lepirudin. Reactions 933: 3, New Zealand, Adis Data Information
8. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C (1991) A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 66: 734-736
9. Greinacher A, Mueller-Eckhardt C (1991) Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116: 1479-1482
10. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. Br J Haematol 84: 711-716
11. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C (1994) Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34: 381-385
12. Greinacher A, Eichler P (1995) Die Heparin-assoziierte Thrombozytopenie - Immunologische Aspekte. Hämost 15: 117-121
13. Greinacher A (1996) Heparin-induzierte Thrombozytopenien. Internist 37: 1172-1178
14. Greinacher A, Völpel H, Pötzsch B (1996) Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). Blood 88: 281A
15. Greinacher A, Eichler R Lubenow N, Kwasny H, Luz M (2000) Heparin- induced thrombocytopenia with thromboembolic complications: meta-analyses of two prospective trials to assess the value of parenteral treatment with lephirudin and its therapeutic aPTT range. Blood 96: 846-851
16. Greinacher A (2001) Hirudin in dervaskulären Medizin. 1. Aufl. Uni-Med, Bremen, S 38-41
17. Griffiths E, Dzik WH (1997) Assays for heparin-induced thrombocytopenia. Trans Med 7: 1-11
18. Haas S (1997) Gegenwärtiger Stand der Diagnose und Therapie der Heparin-induzierten Thrombozy-topenie (HIT). J Anästhesie Intensiv 4: 3-4
19. Hach-WunderleV, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet 344: 469-470
20. King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100: 535-540
21. Lubenow N, Eichler P, Greinacher A (2002) Results of a large drug monitoring program confirms the safety and efficacy of Refludan (lephirudin) in patients with immune mediated heparin-induced thrombocytopenia (HIT). ASH-Kongress A1955
22. Magnani HN (1997) Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia. Platelets 8: 74-81
23. Magnani HN, Rieckhof B (1998) Heparin-induzierte Thrombozytopenie: Tatsächliche Ergebnisse im Vergleich zu theoretischen Überlegungen einer Therapie mit Orgaran®. J Anaesth Intensiv 5: 23-28
24. Magnani HN (1998) Management of heparin-induced thrombocytopenia. Br Med J 307: 203-204
25. Makhoul RG, Greenberg CS, McCann RL (1986) Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 4: 522-528
26. Nelson JC, Lerner RG, Goldstein R (1978) Heparin-induced thrombocytopenia. Arch Intern Med 138: 548-552
27. Pötzsch B, Unkrig C, Madlener K, Greinacher A, Müller-Bergbaus G (1996) APC resistence and early on-set of oral anticoagulation are high thrombotic risk factors in patients with heparin-associated thrombocytopenia (HAT). Ann Haematol 72: A6
28. Rösel T, Druschky KF, Greinacher A (1999) Die heparininduzierte Thrombozytopenie vom Typ II (HIT-Typ II): Komplikationen, Diagnostik und Therapie. Akt Neurologie 26: 25-30
29. Reininger CB, Greinacher A, Lasser R, Steckmeier B, Schweiberer L (1997) Wirkungen von Heparin auf Thrombozyten bei Patienten mit peripherer arterieller Verschlusskrankheit. J Anästhesie Intensiv 4: 8-14
30. Suh JS, Mohammed IM, Aster RH, Visentin GP (1997) Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol 54: 196-201
31. Visentin GP, Malik M, Cyganiak KA, Aster RH (1996) Patients treted with unfractionated heparin during open heart surgery are at risk to form antibodies reactive with heparin-platelet factor 4 complexes. J Lab Clin Med 128: 376-383
32. Warkentin TE, Kelton JG (1989) Heparin-induced thrombocytopenia. Annu Rev Med 40: 31-44
33. Warkentin TE, Kelton JG (1991) Heparin-induced thrombocytopenia. In: Coller BS (ed): Progress in Hemostasis and Thrombosis, vol 10. VB Saunders Comp, Philadelphia, pp 1-34
34. Warkentin TE, Levine MN, Hirsh J (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractioned heparin. N Eng J Med 332: 1330-1335
35. Warkentin TE, Levine MN, Hirsh J, Klama LN, Kelton JG (1995) Formation of heprain-induced thrombocytopenia IgG without thrombocytopenia: analysis of a clinical trial. Blood 86: 537a
36. Warkentin TE, Kelton JG (1996) A 14-year study of heparin-induced thrombocytopenia. Am J Med 101: 502-507
37. Warkentin TE (1996) Danaparoid (Orgaran) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (XR) of danaparoid for HIT IgG. Blood 88: 626A
38. Warkentin TE (1996) Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Trans Med Rev 10: 249-258
39. Warkentin TE, Elavathil LJ, Hayward CPM (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Am J Med 101: 502-507
40. Warkentin TE, Elavathil LJ, Hayward CPM, Johnston MA, Russett JI, Kelton JG (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 127: 804-812
41. Warkentin TE, Chong BH, Greinacher A (1998) Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79: 1-7
42. Warkentin TE, Greinacher A (2001) Heparin-induced thrombocytopenia. In: Goldhaber SZ, Bounameaux H (eds) 43-86. Marcel Dekker, New York